Prediction of Amyloidosis from Neuropsychological and MRI Data for Cost Effective Inclusion of Pre-symptomatic Subjects in Clinical Trials.
Manon AnsartStéphane EpelbaumGeoffroy GagliardiOlivier ColliotDidier DormontBruno DuboisHarald HampelStanley DurrlemanPublished in: DLMIA/ML-CDS@MICCAI (2017)
Keyphrases
- cost effective
- mri data
- clinical trials
- mild cognitive impairment
- ad patients
- fully automatic
- magnetic resonance imaging
- mr images
- low cost
- synthetic data
- magnetic resonance images
- white matter
- decision support system
- cost effectiveness
- imaging modalities
- dt mri
- brain tissue
- mr imaging
- magnetic resonance
- human subjects
- real world
- medical images
- tensor field
- real time
- cross sectional
- expert systems
- high resolution
- experimental design
- database
- image data